A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency
Clinical trial NCT02873975 · COMPLETED
Trial details
- NCT number
- NCT02873975
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-12
- Primary completion
- 2020-09-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.